MDI Guidance Dose Content Uniformity Specs Are Too Restrictive, Firms Say
Acceptance criteria for dose content uniformity in FDA's metered-dose inhaler guidance is too restrictive, Glaxo Wellcome and other MDI manufacturers asserted in comments to the agency.
You may also be interested in...
FDA dose content uniformity standards could be replaced by IPAC-RS standards, the agency said during the Pharmaceutical Science Advisory Committee meeting March 13
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011